Results 131 to 140 of about 27,164 (223)

Somatosensory Evoked Potentials in Spinocerebellar Ataxia Type 3 and Type 10. [PDF]

Cerebellum
Coutinho L, Fustes OJH, Camargo CHF, Stoliar GA, Germiniani FMB, Raskin S, Ashizawa T, Kay CSK, Lorenzoni PJ, Ducci RD, Scola RH, Teive HAG.   +11 more
europepmc   +1 more source

Developing an antisense oligonucleotide treatment for Spinocerebellar Ataxia Type 3

, 2018
Spinocerebellar ataxia type 3 (SCA3) is a hereditary neurodegenerative disorder caused by a CAG triplet repeat expansion in the ATXN3 gene. This expanded CAG repeat is translated into a toxic polyglutamine repeat in the ataxin-3 protein.
Toonen, L.J.A.
core  

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]

Exp Ther Med
Chiu C, Cheng W, Lin T, Chang H, Chang Y, Su S, Lee C, Chang H, Liu C.   +8 more
europepmc   +1 more source

Relationship of subclinical lung injury to chronic airway inflammation in spinocerebellar ataxia type 3. [PDF]

Orphanet J Rare Dis
Lv XT, Lin W, Ye BN, Zhang ZW, Lin H, Zhang JY, Zhou ZY, Cui ML, Huang ZY, Wang N, Gan SR, OSCCAR Investigators.   +11 more
europepmc   +1 more source

Association of spinocerebellar ataxia type 3 and spinocerebellar ataxia type 8 microsatellite expansions: Genetic counseling implications [PDF]

Movement Disorders, 2008
Sabrina Paganoni, Christina A. Seelaus, Kelly E. Ormond, Puneet Opal   +3 more
openaire   +1 more source

Rad23b exacerbates pathological aggregates through disrupting proteasome functions in Spinocerebellar ataxia type 3. [PDF]

Neurotherapeutics
Chen YC, Tung CW, Chan SC, Wu PM, Cheng PH, Chen CM, Yang SH.   +6 more
europepmc   +1 more source

Association Between Cerebellar Metabolic Markers and Activities of Daily Living in Patients With Spinocerebellar Ataxia Type 3. [PDF]

Mol Genet Genomic Med
Ye M, Qiu XP, Zhang S, Wang L, Gao Z, Liu M, Feng Y.   +6 more
europepmc   +1 more source

Peripheral and autonomic nervous system involvement in spinocerebellar ataxia type 3: unveiling an invisible burden. [PDF]

J Neurol
Leeuwenberg KE, van Alfen N, van de Warrenburg BP, Maas RPPWM.   +3 more
europepmc   +1 more source

Extracellular vesicles-mediated delivery of SpCas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3. [PDF]

Biomaterials
Leandro K, Rufino-Ramos D, Lopes SM, Silva FS, Rodrigues-Santos P, Silva AC, Fernandes AR, Henriques C, Pereira D, Lobo D, Gabriel GL, Faro R, Nobre RJ, Perdigão PRL, Kleinstiver BP, de Almeida LP.   +15 more
europepmc   +1 more source

Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichment. [PDF]

EBioMedicine
Baumeister H, Wegner P, Ferreira M, Schaprian T, França MC, Rezende TJR, Muro Martinez AR, Jiang H, Chen Z, Weihua L, Grobe-Einsler M, Koyak B, Önder D, van de Warrenburg B, van Gaalen J, Durr A, Coarelli G, Synofzik M, Schöls L, Giunti P, Garcia-Moreno H, Öz G, Joers J, Timmann D, Thieme AG, Jacobi H, de Vries J, Barker P, Onyike C, Ratai EM, Schmahmann JD, Reetz K, Infante J, Huebener-Schmid J, Kuegler D, Klockgether T, Berron D, Faber J, DELCODE/DANCER, ESMI MRI Study Groups.   +39 more
europepmc   +1 more source